ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
63 201,97
-0,84%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. L'Europe
  5. EU
  6. Quantum Genomics (ALQGC)

  7. Quantum Genomics (ALQGC) Actualités

ALQGC

Quantum Genomics (ALQGC)

Quantum Genomics
De:
Trier par:
 Showing the most relevant articles for your search:EU:ALQGC
DateHeureSourceTitreSymboleSociété
28/10/202208h00GlobeNewswire Inc.Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New DevelopmentsEU:ALQGCQuantum Genomics
06/10/202218h00GlobeNewswire Inc.Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per ShareEU:ALQGCQuantum Genomics
05/10/202218h00GlobeNewswire Inc.Quantum Genomics Publishes its 2022 First Half Results and Reviews its ActivityEU:ALQGCQuantum Genomics
26/09/202216h06GlobeNewswire Inc.Quantum Genomics Announces That the Results Obtained with Firibastat in its Phase III Study, FRESH Will Now be Presented on November 7, 2022, During the AHA Conference in a Session Dedicated to Resistant HypertensionEU:ALQGCQuantum Genomics
27/06/202218h47GlobeNewswire Inc.Quantum Genomics announces the appointment of its new Scientific Advisory BoardEU:ALQGCQuantum Genomics
09/05/202218h00GlobeNewswire Inc.Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESHEU:ALQGCQuantum Genomics
04/05/202218h00GlobeNewswire Inc.Quantum Genomics Appoints Sarah Merlen Boulenger as Head of Regulatory AffairsEU:ALQGCQuantum Genomics
28/04/202218h00GlobeNewswire Inc.Quantum Genomics Publishes its Results for Fiscal Year 2021 and Provides a Corporate UpdateEU:ALQGCQuantum Genomics
27/04/202214h20GlobeNewswire Inc.Quantum Genomics Announces Successful Capital Raise with a Gross Sum of Approximately 15.6M€EU:ALQGCQuantum Genomics
26/04/202217h35GlobeNewswire Inc.Quantum Genomics Raises a Gross Amount of Approximately € 15 MEU:ALQGCQuantum Genomics
31/03/202218h00GlobeNewswire Inc.Quantum Genomics Announces Publication of a New Scientific Article Featuring QGC606EU:ALQGCQuantum Genomics
28/03/202219h35GlobeNewswire Inc.Quantum Genomics Announces Granting of New Patents Protecting QGC606EU:ALQGCQuantum Genomics
14/03/202218h00GlobeNewswire Inc.Stéphane Cohen Joins Quantum Genomics as Director of Global OperationsEU:ALQGCQuantum Genomics
06/12/202108h00GlobeNewswire Inc.Quantum Genomics Signs an Exclusive License and Production Agreement with Gulf Pharmaceuticals Industries JulpharEU:ALQGCQuantum Genomics
25/11/202118h00GlobeNewswire Inc.Quantum Genomics signs an exclusive license agreement with Teva Israel Ltd.EU:ALQGCQuantum Genomics
07/10/202118h00GlobeNewswire Inc.Quantum Genomics and its Partners Reach a New Stage of Development in AsiaEU:ALQGCQuantum Genomics
27/08/202110h45GlobeNewswire Inc.Quantum Genomics Presents Results from Phase IIb QUORUM Study of Firibastat in Heart Failure at the European Society of Cardiology MeetingEU:ALQGCQuantum Genomics
08/07/202108h00GlobeNewswire Inc.Quantum Genomics Enrolls First Patient in Its Pivotal Phase III REFRESH Trial of Firibastat in Difficult-to-Treat and Resista...EU:ALQGCQuantum Genomics
05/07/202108h00GlobeNewswire Inc.Presentation of the Effects of QGC606 in an Experimental Model of Heart Failure at the Annual Congress of the European Societ...EU:ALQGCQuantum Genomics
19/05/202118h40GlobeNewswire Inc.Quantum Genomics Announces the Publication of New Scientific Article in Biomedicine & Pharmacotherapy Which Further Strengthe...EU:ALQGCQuantum Genomics
28/04/202118h03GlobeNewswire Inc.Quantum Genomics Secures €3 Million Non-dilutive FinancingEU:ALQGCQuantum Genomics
21/04/202108h00GlobeNewswire Inc.Quantum Genomics Will Present Top-line Results From its QUORUM Study of Firibastat in Heart Failure Post Myocardial Infarctio...EU:ALQGCQuantum Genomics
20/04/202108h00GlobeNewswire Inc.Quantum Genomics Announces the End of its Collaboration with Qilu for the Development and Commercialization of Firibastat in ...EU:ALQGCQuantum Genomics
25/03/202118h00GlobeNewswire Inc.Quantum Genomics Reports Full Year 2020 Operating and Financial ResultsEU:ALQGCQuantum Genomics
09/02/202118h00GlobeNewswire Inc.Orient EuroPharma Acquires Equity Stake in Quantum GenomicsEU:ALQGCQuantum Genomics
09/10/201813h43GlobeNewswire Inc.Edison issues update on Quantum Genomics (ALQGC)EU:ALQGCQuantum Genomics
24/03/201613h00GlobeNewswire Inc.Quantum Genomics Raises €8.6 Million in U.S. and EuropeEU:ALQGCQuantum Genomics
03/02/201620h21GlobeNewswire Inc.Quantum Genomics Expands U.S. Presence to Advance Its Development Programs for Cardiovascular DiseasesEU:ALQGCQuantum Genomics
 Showing the most relevant articles for your search:EU:ALQGC

Dernières Valeurs Consultées

EU
LR
Legrand
FTSE
UKX
FTSE 100
SPI
SP500
S&P 500
EU
RI
Pernod Ricard
NYSE
DIS
Walt Disney
EU
RNO
Renault
EU
CAP
Capgemini
EU
MC
Lvmh Moet Hennessy Louis...
EU
ACA
Credit Agricole
EU
VIV
Vivendi
EU
DG
Vinci
EU
ML
Michelin
COIN
BTCUSD
Bitcoin
USI
USTECH100
US Tech 100
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés